Medullary Thyroid Cancer (MTC) During early laboratory studies, researchers found that GLP-1 medications caused an increase in C-cell tumours and medullary thyroid cancer (MTC) in rats and mice
While it has gained popularity due to its ability to stimulate fat metabolism without increasing IGF-1 levels, its essential to understand how it differs from other peptides like hGH, CJC-1295, Ipamorelin, and Semaglutide (Ozempic)
Your best results depend on realistic expectations, physician expertise, and a stable treatment weight
Common reasons for compounding include: Eliminate allergens or potential irritants Providing dosages that are not commercially available Patients who may require lower dosages Formulations that may be more suitable for a specific patient It may be a more affordable option for some patients More convenient for some patients to consume Differences from Brand-Name Versions The difference here is not just with the formulation
Symptoms include severe stomach pain, sometimes radiating to the back, with or without vomiting
Result: significant muscle loss (20-30% of weight lost)